Farms.com Home   News

Rain Chances Finally Improve After a Dry Start to May

By Pam Knox
 
The forecast for rain on Saturday did not look too hopeful for rain in Georgia, but the latest forecast released today looks a lot more favorable for at least an inch of rain this week. We won’t see much if anything from Tropical Storm Arthur, which will be off to our east, but a complex system of fronts and a cut-off low are expected to bring an inch to central Georgia and potentially several inches to the northeast mountains in the next week. The driest period is likely to be next weekend, with showers on and off this week. On Monday there is a slight chance of severe weather, especially in the northeast part of Georgia, but it is not expected to be a big outbreak if anything materializes. Keep an eye out just in case. The rain is sorely needed as we have had almost no rain in the first half of May, although temperatures have been quite cool, and producers have been worried about going into a flash drought. Hopefully the rain this week will give everyone some hope of a return to a wetter pattern.

 

Source : uga.edu

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.